Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If ADXS is trading under $1 for the next five months, the NASDQ will be sending Berlin a delisting notice. That will force Berlin to execute ANOTHER ADXS reverse split to get the ADXS share price over $1. Another negative for ADXS shareholders, dreamers & bag holders.
Head & neck cancer news:
"Shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) were 13.3% higher as of 11:12 a.m. EDT on Tuesday. The clinical-stage biotech announced the publication of results in Clinical Cancer Research, a major cancer journal, from a study of MEDI0457.
The data published in the journal focused on one patient in the study who experienced full remission from head and neck cancer after being treated by MEDI0457 followed by treatment with a PD-1 checkpoint inhibitor -- a type of cancer immunotherapy. This complete response by one patient has been sustained for more than two years."
Not good news for ADXS shareholders as con man Ken Berlin failed, just as I posted he would, to close a cash deal for ADXS HOT head & neck which is based on the still totally unproved ADXS "LM Technology" after over seven years of FDA trials. BP did not get duped by Berlin's con game.
"Warrants are dead, stock is in coma."..... ADXS warrant holders were executed by con man Ken Berlin. ADXS shareholders & bag holders are on life support & it has finally dawned on them that they were totally duped by Berlin's ADXS con game.
Wanted for the murder, con man Ken Berlin. Berlin will burn in hell for stabbing the long suffering ADXS warrant holders in the back when he easily could have been a hero, instead of a murderer, by extending the ADXS warrants which he refused to do.
"Doc and TL couldn't get any deals signed in 2 years despite outstanding data. I believe the lack of closing is directly related to personalities and abilities of the leadership which was poor." ..... Pure BS nonsense. DOC did many deals with clinical partners, licensing agreements & institutes & foundations. https://www.advaxis.com/partners/
" If the deal is not weak, that would send a strong message to the markets." ...Judging by the ADXS share price reaction to this osteosarcoma deal news, just like most of the other ADXS "deals", the market is sending a very strong message that this deal is extremely weak. Berlin doesn't have the testicular fortitude to disclose how much, if any, upfront cash is involved. Just like ADXS failed to disclose what, if any, the Amgen NEO milestone payments are or aren't
"Oh, you’re going to play the “proof” game? You go ahead and prove the warrant agreement specifically precludes extension." ... I asked you to post proof of your post that the ADXS Oct 5 option expiration can be extended which you can't do because exchange traded options can't be extended after they expire. The warrants can be extended if Berlin chooses to extend the expiration date. Wrong again as usual.
"“The option expiration can not be extended.”
False."... Wrong again. Post proof that the ADXS Oct 5 call that expires Oct 18th CAN be extended after Oct 18th expiration.
"Mr. Market saying warrants may potentially be in the money (above $5 strike price) come October 15." ......Mr. Market is saying no such thing. The Oct 5 options that expire Oct 18th current quote is .00 bid - .05 asked. The ONLY reason that the warrant is not trading at the same price is speculation that the warrants may be extended before expiration. The option expiration can not be extended.
"Who would benefit most from keeping the terms and the payment schedule secret? ADXS or AMGN?" .... ADXS is the culprit. The NEO deal with Amgen was so poor for ADXS shareholders, that ADXS insisted on the gag order. Amgen has no reason to keep the terms secret because with every milestone payment from Amgen clearly displays that Amgen has confidence that NEO could be the real deal.
" Amgn stole NEO for pennies on the dollar" ....Post the proof of this statement.
"HOT partner with AMGEN !!!!!!New Presentation is up! page 14 HOT partnership with AMGEN!!!! is that true or type error?" ... It's an error. Look on page 18 where it clearly states under partnering plans that HOT is "In discussion with multiple parties", NOT that Amgen is partnering with ADXS for HOT.
"Ant that offering will be 30m shares at a buck or less" ...When Berlin does a funding it wont be at a buck or less. One of the reasons Berlin will announce another big time reverse split either before or as part of the funding is that when ADXS goes under $1 for 30 days it will be delisted from the NASDQ. Mighty embarrassing black eye for Ken Berlin, the brand new ADXS CEO
ADXS will release it's earnings report on a very infamous day for the USA, 9/11.
Considering the Affimed deal, it will be a monumental success for Berlin to close a deal similar to Affimed. It will be a monumental failure if Berlin fails to close a big deal similar to Affimed. Deal or No Deal?
IF Berlin had any big cash deals for AXAL & HOT in his pocket, there is no need for the S3 filing at this time or any more mass dilution as ADXS would be flush with cash.
Bottom line is if any BP believed the ADXS "LM Technology", the basis for AXAL & HOT, was the real deal, BP would be breaking Berlin's door down to put up big time upfront cash to partner for AXAL & HOT. AXAL is in phase 3 trials & Berlin can't find a cash partner. HOT hasn't started any trials & even with all the HOT HYPE, Berlin can't find a cash partner. It certainly appears that BP has no confidence in ADXS "LM Technology", AXAL or HOT.
"Imho Ken made a key mistake when he announced he would wind down axal if no partner. Why would any one buy with that looming? Don't understand the strategy for announcing that," .......Con man Ken Berlin knows that AXAL is a dud & would not get FDA or EU approval. In order to NOT have to mass dilute with another funding immediately after being appointed CEO, Berlin threw AXAL under the bus even thought AXAL is in phase 3 trials. AXAL is ADXS leading "LM Technology" vaccine that was going to prove the Listeria technology was the real deal. Berlin will shelve AXAL because he knows AXAL is not the real deal. That is why Berlin fails to find a cash partner for AXAL. Berlin then started the next part of the con. In order to justify shelving AXAL, con man KB embarked on a HYPE NEO & HOT strategy, claiming that both NEO & HOT are far superior vaccines than AXAL even though the ADXS "LM Technology" is the base for all three vaccines & LM is still just another unproved technology. The market didn't buy what con man Ken Berlin is selling.
"The skinny. If Ken doesn't close a deal SOON, expect another dilution for 30m shares at 75 cents a share by next January-February at the latest." ..Berlin won't dilute at .75 cents a share. Berlin will institute another monster reverse split before he foists more mass dilution onto all ADXS shareholders.
Legitimate, crucial ADXS questions to answer. IF/WHEN Berlin fails to close any big cash deals for AXAL & HOT, how will con man Ken Berlin fund ADXS to keep the corpse alive? What ramifications will it have on the credibility of ADXS "LM Technology" WHEN/IF no BP steps up to the plate with big time cash for AXAL & HOT? No meaningless responses like "no way that will happen".
""con man Ken Berlin"?
Would you be so kind as to provide proof of this?" .....ADXS share price down 12% since Berlin was appointed CEO tells the story. The market is clearly not buying what con man Ken Berlin is selling.
"What an absurd statement. IF Ken cannot find a partner for AXAL it will be because ADXS topped AXAL already with NEO and HOT and, thus, DOC waited too long. If nobody wants AXAL then it would only be because the market believes that NEO and HOT will be even better." ... Post proof that this ludicrous statement is nothing more than another load of nonsense BS which it is.
"To me this points more to them shelving AXAL for the time being, just like Ken alluded to on the call."...Con man Ken Berlin will shelve phase 3 AXAL in favor of the incredibly overhyped HOT. AXAL & HOT are both based on ADXS unproved "LM Technology". Berlin can't find a cash partner for AXAL or HOT. Con man Ken Berlin is trading phase 3 AXAL for the overhyped HOT which has not even started phase 1. Makes sense to me.
"Nonsense. ADXS’s AXAL results have all been good-to-stellar, and Amgen has made NEO a cornerstone of its pipeline." ....What an absurd statement. The AXAL results have been so good that con man Ken Berlin can't find a cash partner for AXAL, will shelve AXAL, & will not continue the phase 3 trial that within two years could prove if AXAL & the "LM Technology" is the real deal or not. NEO is NOT the cornerstone of Amgen's pipeline. Amgen has many other irons in the fire other than NEO.
"Nonsense. The AXAL data has all been good, including GOG data that was better than that for a multi-billion dollar drug that is the current standard of care." ....The AXAL data has been so good that after seven years of trials & now in phase 3, that NO BP is willing to be a big cash partner for AXAL. BP should be knocking Berlin's door down to have the chance to partner with phase 3 AXAL. Should be a no brainer for any BP, but not even Amgen is knocking on Berlin's AXAL door.
"There is zero evidence that AXAL doesn’t work as touted. Name the trial failure. HOT is second generation AXAL, and anyone with a clue would bet that it will be better than AXAL, same as NEO." ...There is zero evidence, after 7 years of trials & millions of dollars of shareholder capital squandered, that the ADXS "LM Technology",which is the basis of AXAL, NEO & HOT, is nothing more than unproved pipe dream.
" A lot of tutes sold because they grew tired of the 3-year declining share price short attack scheme." ...The gullible tutes were easily duped by totally the unproved, & still unproved, ADXS LM Technology & AXAL hype. When these geniuses finally realized that AXAL & the LM technology was a dud, they unloaded.
"That is your opinion. I disagree, and we will see." ... The facts are that my opinions about ADXS have been 100% correct while your opinions about ADXS has been 100% wrong.
"The manipulation, more so done in the past but continuing, certainly has limited their financing options." ... Pure nonsense. The only reason the ADXS share price has collapsed from $30 & why ADXS has limited financing options was NOT manipulation, HFT evil market makers etc. It's because BP, the market & the shorts know that AXAL is a dud & wouldn't get FDA or EU approval. ADXS "LM technology" still remains a totally unproved pipe dream . LM technology is the basis for AXAL, NEO & HOT.
"Negative. HOT has value, and so does AXAL. PSA combo license with Merck. Licensing deals will be available.".. Licensing deals for AXAL have been available for seven years & even though AXAL is in phase 3 trials, con man Ken Berlin still can't find a big up front cash partner. HOT is nothing more than an overhyped, totally unproved pipe dream as is the entire ADXS LM technology that AXAL, HOT & NEO are based on.
Con man Ken Berlin will shelve AXAL when Berlin fails to find a big upfront cash partner. In sharp contrast, INOVIO continues with trials of their HPV vaccine: "VGX-3100 human papillomavirus (HPV) vaccine
Inovio's VGX-3100 vaccine for treating cervical dysplasia caused by HPV rounds out the list of top vaccines in development. VGX-3100 could generate sales of $622 million in 2024 if approved.
After a delayed start to its phase 3 clinical study of VGX-3100 due to an FDA clinical hold in 2016, everything now appears to be on track. Inovio reported last week that phase 3 enrollment is on schedule with 70 sites in 16 countries enrolling patients.
"I know you are praying for dilution but I do not consider it a viable option. But good luck with your dream." ...I know you are praying for NO DILUTION. Good luck with your dream but your dream will be a nightmare of mass dilution & another monster reverse split.
"It is clear that the only two options are either significant licensing deals or a buyout. The withdrawal of the EMA made this even more apparent." ... I posted many times that AXAL will not get FDA or EU approval. The third option that you neglected to post is the most likely option. No buyout, No big upfront cash licensing deals. Con man Ken Berlin will foist big time mass dilution onto ADXS shareholders with a new funding that includes another monster reverse split to keep this rotting corpse alive.
"Sell the beech.....$1b would be greAt at this point" ..... What BP is going to pay $1b when the LM Technology after 7 years of trials & millions of dollars squandered is still just a totally unproved pipe dream? Certainly not Amgen.
"Companies don’t extend warrants until just before expiration." For the sake of the warrant holders, I hope you are right for a change. Betting on con man Ken Berlin to do the right thing by warrant holders is a very dicey proposition.
"Rather than being a “crime against humanity,” as you alleged, shutting down the AXAL program in cervical cancer would scarcely be noticed by the medical community." ... Very true statement. No one, especially in the medical community will notice that AXAL is shut down except the ADXS warrant & shareholders who were duped into believing that the totally unproved ADXS LM Technology was the real deal & lost all the money they gambled in ADXS.
"I just can't see them raising enough cash to get ahead of the curve. The science is a long way out to be proven." .....Finally you are seeing ADXS for what it truly is, why ADXS stock collapsed from $30 & why con man Ken Berlin fails to find upfront cash partners for AXAL or HOT. It wasn't manipulation, HFT, shorts, evil market makers that collapsed the stock. It collapsed because the ADXS LM technology, the basis for AXAL & HOT is, after 7 long years of trials & hype still a totally unproved pipe dream. Con man Ken Berlin will shelve AXAL, fail to get a cash partner for HOT & then foist more mass dilution on ADXS shareholders, after another monster reverse split, to keep this rotting corpse alive. Berlin already shot dead all the warrant holders by NOT extending the warrant expiration when that is what he should do.
RCauto has abandoned this sinking BSTN ship months ago.
"Great expectations from Ken.
1) Save the warrants. May be this is what will happen as a saving grace in the September CC.
2) Get a deal done and infuse cash into the company - his real test and he has a few months(EOY at most) before he runs out of time and cash crisis looms." .......... Great expectations will be great disappointments as con man Ken Berlin fails to deliver the goods.
"Why not do it, at least for a year or two to make up for Lombardo and DOC?" ..... Certainly The warrants should be extended immediately, but they won't be because con man Ken Berlin has nothing but disdain, disrespect & zero regard for warrant holders & that is the reason Berlin has shot the warrant holders dead.